Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cat-1004
1. 1204317-86-1
2. Cat-1004
3. Edasalonexent [inn]
4. Edasalonexent [usan]
5. Af3z6434ks
6. Cat 1004
7. N-[2-[[(4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]ethyl]-2-hydroxybenzamide
8. Benzamide, 2-hydroxy-n-(2-(((4z,7z,10z,13z,16z,19z)-1-oxo-4,7,10,13,16,19-docosahexaen-1-yl)amino)ethyl)-
9. Unii-af3z6434ks
10. Amy350
11. Schembl1823117
12. Chembl3786673
13. Who 10223
14. Db15010
15. Hy-17630
16. Cs-0016786
17. Q27273902
18. N-(2-((4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenamido)ethyl)-2-hydroxybenzamide
19. N-(2-(4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16, 19-hexaenamidoethyl)-2-hydroxybenzamide
20. N-(2-(4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenamidoethyl)-2-hydroxybenzamide
| Molecular Weight | 490.7 g/mol |
|---|---|
| Molecular Formula | C31H42N2O3 |
| XLogP3 | 7.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 18 |
| Exact Mass | 490.31954321 g/mol |
| Monoisotopic Mass | 490.31954321 g/mol |
| Topological Polar Surface Area | 78.4 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 762 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 6 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Edasalonexent manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Edasalonexent, including repackagers and relabelers. The FDA regulates Edasalonexent manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Edasalonexent API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Edasalonexent supplier is an individual or a company that provides Edasalonexent active pharmaceutical ingredient (API) or Edasalonexent finished formulations upon request. The Edasalonexent suppliers may include Edasalonexent API manufacturers, exporters, distributors and traders.
Edasalonexent Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Edasalonexent GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Edasalonexent GMP manufacturer or Edasalonexent GMP API supplier for your needs.
A Edasalonexent CoA (Certificate of Analysis) is a formal document that attests to Edasalonexent's compliance with Edasalonexent specifications and serves as a tool for batch-level quality control.
Edasalonexent CoA mostly includes findings from lab analyses of a specific batch. For each Edasalonexent CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Edasalonexent may be tested according to a variety of international standards, such as European Pharmacopoeia (Edasalonexent EP), Edasalonexent JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Edasalonexent USP).
LOOKING FOR A SUPPLIER?
